In a study of melanoma cell lines, the investigators found that inhibiting NLRP3 using OLT1177, caused suppression of IL-1β mediated inflammation by disrupting the IL-1β/IL-6/STAT3 axis (Tengesdal et al. 2021). This evidence concerns the gene IL1B and melanoma.